Search Results

There are 6965 results for: content related to: Cutaneous tumor cell load correlates with survival in patients with Sézary syndrome

  1. U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma

    British Journal of Dermatology

    Volume 168, Issue 1, January 2013, Pages: 192–200, J.J. Scarisbrick, S. Morris, R. Azurdia, T. Illidge, E. Parry, R. Graham-Brown, R. Cowan, E. Gallop-Evans, R. Wachsmuth, M. Eagle, A.S. Wierzbicki, H. Soran, S. Whittaker and E.M. Wain

    Version of Record online : 3 DEC 2012, DOI: 10.1111/bjd.12042

  2. Retinoids

    Standard Article

    Burger's Medicinal Chemistry and Drug Discovery

    Marcia I. Dawson

    Published Online : 15 SEP 2010, DOI: 10.1002/0471266949.bmc065.pub2

  3. Bexarotene therapy for mycosis fungoides and Sézary syndrome

    British Journal of Dermatology

    Volume 160, Issue 6, June 2009, Pages: 1299–1307, R.A. Abbott, S.J. Whittaker, S.L. Morris, R. Russell-Jones, T. Hung, S.J. Bashir and J.J. Scarisbrick

    Version of Record online : 16 FEB 2009, DOI: 10.1111/j.1365-2133.2009.09037.x

  4. You have free access to this content
    Efficacy and safety of bexarotene combined with psoralen–ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB–IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial 21011 (NCT00056056)

    British Journal of Dermatology

    Volume 167, Issue 3, September 2012, Pages: 678–687, S. Whittaker, P. Ortiz, R. Dummer, A. Ranki, B. Hasan, B. Meulemans, S. Gellrich, R. Knobler, R. Stadler and M. Karrasch

    Version of Record online : 27 AUG 2012, DOI: 10.1111/j.1365-2133.2012.11156.x

  5. You have free access to this content
    Absence of modulation of CD4+CD25high regulatory T cells in CTCL patients treated with bexarotene

    Experimental Dermatology

    Volume 19, Issue 8, August 2010, Pages: e95–e102, Anne Chantal Knol, Gaëlle Quéreux, Anabelle Brocard, Fabienne Ballanger, Amir Khammari, Jean-Michel Nguyen and Brigitte Dréno

    Version of Record online : 21 OCT 2009, DOI: 10.1111/j.1600-0625.2009.00993.x

  6. The optimal use of bexarotene in cutaneous T-cell lymphoma

    British Journal of Dermatology

    Volume 157, Issue 3, September 2007, Pages: 433–440, R. Gniadecki, C. Assaf, M. Bagot, R. Dummer, M. Duvic, R. Knobler, A. Ranki, P. Schwandt and S. Whittaker

    Version of Record online : 6 JUN 2007, DOI: 10.1111/j.1365-2133.2007.07975.x

  7. Topical and oral bexarotene

    Dermatologic Therapy

    Volume 26, Issue 5, September/October 2013, Pages: 400–403, Courtney R. Schadt

    Version of Record online : 4 OCT 2013, DOI: 10.1111/dth.12087

  8. Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion

    British Journal of Dermatology

    Volume 155, Issue 2, August 2006, Pages: 261–266, C. Assaf, M. Bagot, R. Dummer, M. Duvic, R. Gniadecki, R. Knobler, A. Ranki, P. Schwandt and S. Whittaker

    Version of Record online : 12 MAY 2006, DOI: 10.1111/j.1365-2133.2006.07329.x

  9. You have full text access to this OnlineOpen article
    Analysis of differential secondary effects of novel rexinoids: select rexinoid X receptor ligands demonstrate differentiated side effect profiles

    Pharmacology Research & Perspectives

    Volume 3, Issue 2, March 2015, Pamela A. Marshall, Peter W. Jurutka, Carl E. Wagner, Arjan van der Vaart, Ichiro Kaneko, Pedro I. Chavez, Ning Ma, Jaskaran S. Bhogal, Pritika Shahani, Johnathon C. Swierski and Mairi MacNeill

    Version of Record online : 16 MAR 2015, DOI: 10.1002/prp2.122

  10. A selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced prostate cancer

    The Prostate

    Volume 66, Issue 3, 15 February 2006, Pages: 305–316, Wan-Ching Yen and William W. Lamph

    Version of Record online : 21 OCT 2005, DOI: 10.1002/pros.20347

  11. You have free access to this content
    Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE−/− mice and angiogenesis

    British Journal of Pharmacology

    Volume 172, Issue 12, June 2015, Pages: 2946–2960, P Escudero, A Navarro, C Ferrando, E Furio, H Gonzalez-Navarro, M Juez, M J Sanz and L Piqueras

    Version of Record online : 26 MAR 2015, DOI: 10.1111/bph.13098

  12. Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma

    British Journal of Dermatology

    Volume 160, Issue 3, March 2009, Pages: 519–526, N. Nieto-Rementería, G. Pérez-Yarza, M.D. Boyano, A. Apraiz, R. Izu, J.L. Díaz-Pérez and A. Asumendi

    Version of Record online : 25 NOV 2008, DOI: 10.1111/j.1365-2133.2008.08931.x

  13. RESEARCH REPORT Bexarotene capsules and gel for previously treated patients with cutaneous T-cell lymphoma: Results of the Australian patients treated on phase II trials

    Australasian Journal of Dermatology

    Volume 42, Issue 2, May 2001, Pages: 91–97, H Miles Prince, Christopher McCormack, Gail Ryan, Christopher Baker, Harvey Rotstein, Jill Davison and Richard Yocum

    Version of Record online : 15 JAN 2002, DOI: 10.1046/j.1440-0960.2001.00488.x

  14. You have free access to this content
    Vitamin D controls apoptosis and proliferation of cutaneous T-cell lymphoma cells

    Experimental Dermatology

    Volume 24, Issue 10, October 2015, Pages: 798–800, Christian Mrotzek, Moritz Felcht, Andrea Sommer, Alexandra Schrader, Claus-Detlev Klemke, Marco Herling, Max Schlaak and Mario Fabri

    Version of Record online : 22 MAY 2015, DOI: 10.1111/exd.12746

  15. You have free access to this content
    A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML

    American Journal of Hematology

    Volume 89, Issue 8, August 2014, Pages: E103–E108, John S. Welch, Haixia Niu, Geoffrey L. Uy, Peter Westervelt, Camille N. Abboud, Ravi Vij, Keith E. Stockerl-Goldstein, Meagan Jacoby, Iskra Pusic, Mark A. Schroeder, John F. Dipersio and Amanda F. Cashen

    Version of Record online : 28 APR 2014, DOI: 10.1002/ajh.23735

  16. Die kutane Tumorzelllast korreliert mit dem Überleben von Patienten mit Sézary-Syndrom

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 11, Issue 1, January 2013, Pages: 67–79, Nina Booken, Jan Peter Nicolay, Christel Weiss and Claus-Detlev Klemke

    Version of Record online : 3 JAN 2013, DOI: 10.1111/j.1610-0387.2012.08027_suppl.x

  17. Combination therapy with extracorporeal photopheresis, interferon-α, PUVA and topical corticosteroids in the management of Sézary syndrome

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 8, Issue 6, June 2010, Pages: 428–438, Nina Booken, Christel Weiß, Jochen Utikal, Moritz Felcht, Sergij Goerdt and Claus-Detlev Klemke

    Version of Record online : 18 FEB 2010, DOI: 10.1111/j.1610-0387.2010.07319.x

  18. Novel Silicon-Containing Analogues of the Retinoid Agonist Bexarotene: Syntheses and Biological Effects on Human Pluripotent Stem Cells

    ChemMedChem

    Volume 6, Issue 8, August 1, 2011, Pages: 1509–1517, Dr. Jennifer B. Bauer, Dr.  W. Peter Lippert, Steffen Dörrich, Dr. David Tebbe, Dr. Christian Burschka, Dr. Victoria B. Christie, Daniel M. Tams, Andrew P. Henderson, Bridgid A. Murray, Prof. Todd B. Marder, Prof. Stefan A. Przyborski and Prof. Reinhold Tacke

    Version of Record online : 1 JUL 2011, DOI: 10.1002/cmdc.201100156

  19. You have free access to this content
    New and established treatment options for mycosis fungoides and Sézary syndrome – an update

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 12, Issue 7, July 2014, Pages: 561–569, Susanne Dugas-Breit, Hans-Joachim Schulze and Christian Hallermann

    Version of Record online : 29 MAY 2014, DOI: 10.1111/ddg.12376

  20. You have free access to this content
    Evolving Insights in the Pathogenesis and Therapy of Cutaneous T-cell lymphoma (Mycosis Fungoides and Sezary Syndrome)

    British Journal of Haematology

    Volume 155, Issue 2, October 2011, Pages: 150–166, Henry K. Wong, Anjali Mishra, Timothy Hake and Pierluigi Porcu

    Version of Record online : 25 AUG 2011, DOI: 10.1111/j.1365-2141.2011.08852.x